Safety of warfarin anticoagulation in patients with heparin-induced thrombocytopenia

Chest

Volumn 116, Issue 5, 1999, Pages 1333-1338

  Wallis, Diane E ^a,c   Quintos, Robert ^b   Wehrmacher, William ^b   Messmore, Harry ^b  

^a Midwest Heart Specialists   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

^c Midwest Heart Research Foundation   (United States)

Author keywords

Heparin induced thrombocytopenia; Heparin induced thrombosis; Treatment of heparin induced thrombocytopenia

Indexed keywords

HEPARIN; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ANTICOAGULATION; ARTICLE; DOSE RESPONSE; DRUG EFFECT; DRUG RESPONSE; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROTHROMBIN TIME; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0032724209     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.116.5.1333     Document Type: Article

References (31)

1. 1 Warkentin TE, Kelton JS. Heparin and platelets. Hematol Oncol Clin N Am 1990; 4:243-264
2. 2 Chong BH. Heparin-induced thrombocytopenia. Br J Hematol 1995; 89:431-439
3. 3 Laster J, Cikrit D, Walker N, et al. The heparin-induced thrombocytopenia syndrome: an update. Surgery 1987; 102: 763-770
4. 4 King DJ, Kelton JG. Heparin-associated thrombocytopenia. Ann Intern Med 1984; 100:535-540
5. 5 Dryjski M, Dryjski H. Heparin induced thrombocytopenia. Eur J Vasc Endovasc Surg 1996; 11:260-269
6. 6 Brieger DB, Mak KH, Dottke-Marchant KH, et al. Heparin-induced thrombocytopenia. J Am Coll Cardiol 1998; 31: 1449-1459
7. 7 Singer RL, Mannion JD, Bauer TL, et al. Complications from heparin-induced thrombocytopenia in patients undergoing cardiopulmonary bypass. Chest 1993; 104:1436-1440
8. 8 Warkentin TE, Kelton JG. Heparin-induced thrombocytopenia. Prog Hemostasis Thromb 1991; 10:1-34
9. 9 Silver D, Kapsch D, Tsoi EK. Heparin-induced thrombocytopenia, thrombosis, and hemorrhage. Ann Surg 1983; 198: 301-306
10. 10 Walls JT, Curtis JJ, Silver D, et al. Heparin-induced thrombocytopenia in open heart surgical patients: sequelae of late recognition. Ann Thorac Surg 1992; 53:787-791
11. 11 Cines DB, Kaywin P, Bina M, et al. Heparin-associated thrombocytopenia. N Engl J Med 1980; 303:788-795
12. 12 Warkentin TE, Hayward CP, Boshkov LK, et al. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia. Blood 1994; 84:3691-3699
13. 13 Cines D, Tomaski A, Tannenbaum S. Immune endothelial cell injury in heparin-associared thrombocytopenia. N Engl J Med 1987; 316:581-589
14. 14 Warkentin TE, Elavathil LJ, Hayward CP, et al. The pathogenesis of venous limb gangrene associated with heparin-induced thrombocytopenia. Ann Intern Med 1997; 127:804-812
15. 15 Raskob GE, George JN. Thrombotic complications of anti-thrombotic therapy: a paradox with implications for clinical practice. Ann Intern Med 1997; 127:839-841
16. 16 Harrison L, Johnston M, Massicotte MP, et al. Comparison of 5-mg and 10-mg loading doses in initiation of warfarin therapy. Ann Intern Med 1997; 126:133-136
17. 17 Hirsh J. Warkentin TE, Raschke R, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing considerations, monitoring, efficacy and safety. Chest 1998; 114(suppl):489S-510S
18. 18 Warkentin TE, Levine MN, Hirsh J, et al. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. N Engl J Med 1995; 332:1330-1335
19. 19 Bauer TL, Arepally G, Konkle BA, et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 1997; 95:1242-1246
20. 20 Visentin GP, Ford SE, Scott JP, et al. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest 1994; 93:81-88
21. 21 Greinacher A, Pötzsch B, Amiral J, et al. Heparin-associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Hemostasis 1994; 71:247-251
22. 22 Amiral J, Bridey F, Wolf M, et al. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases. Thromb Hemostasis 1995; 73:21-28
23. 23 Kelton JG, Smith JW, Warkentin TE, et al. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4. Blood 1994; 83:3232-3239
24. 24 Horne MK III, Alkins BR. Platelet binding of IgC from patients with heparin-induced thrombocytopenia. J Lab Clin Med 1996; 127:435-442
25. 25 Mohiuddin SM, Hilleman DE, Destache CJ, et al. Efficacy and safety of early versus late initiation of warfarin during heparin therapy in acute thromboembolism. Am Heart J 1992; 123:729-732
26. 26 The Stroke Prevention in Atrial Fibrillation Investigators. Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial. Lancet 1996; 348:633-638
27. 27 Hylek EM, Skates SJ, Sheehan MA, et. al. An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med 1996; 335:540-546
28. 28 Gurwitz JH, Monette J, Rochon PA, et al. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting. Arch Intern Med 1997; 157:978-984
29. 29 Lewis BE, Walenga JM, Wallis DE. Anticoagulation with Novastan (argatroban) in patients with heparin-induced thrombocytopenia and heparin-induced thrombocytopenia and thrombosis syndrome. Semin Thromb Hemost 1997; 23:197-202
30. 30 Greinacher A, Völpel H, Janssens U, et al. Recombinant hiruden (lepirudin) provides sate and effective anticoagulation in patients with heparin-induced thrombocytopenia: a prospective study. Circulation 1999; 99:73-80
31. 31 Walenga JM, Fasanella A, Iqbal O, et al. Coagulation laboratory testing in patients treated with argatroban. Semin Thromb Hemost 1999; 25(suppl 1):61-66